Breaking News Instant updates and real-time market news.

BDN

Brandywine Realty

$12.96 /

+0.1 (+0.78%)

16:42
04/20/22
04/20
16:42
04/20/22
16:42

Brandywine Realty reports Q1 FFO 35c, consensus 34c

Reports Q1 revenue $127.505M, consensus $120.94M. "We continue to experience increased levels of physical occupancy and traffic as tenants focus on higher quality, well amenitized buildings," stated Gerard H. Sweeney, President and Chief Executive Officer for Brandywine Realty Trust. "During the first quarter, we made excellent progress on our 2022 business plan. At the midpoint of our range, we have achieved 84% of our speculative revenue target and, for the quarter, experienced mark-to-market rents increase 20.4% and 12.9% on an accrual and cash basis, respectively. From a development standpoint our 405 Colorado project in Austin, Texas is now over 80% leased and our development projects continue to see increasing tenant activity. Turning to capital markets, we are excited to acquire a 20% interest in Cira Square with two high quality partners and control an 863,000 square foot property in University City. We funded our portion of the acquisition through the sale of a vacant land parcel located in Washington, DC. Our balance sheet and liquidity remain strong during the quarter and we continue to make excellent progress on our life science development initiatives."

  • 21

    Apr

  • 18

    May

OTHER BREAKING NEWS FROM THE FLY

Initiation
Hygeia Healthcare initiated with a Neutral at Goldman Sachs » 10:47
08/09/22
08/09
10:47
08/09/22
10:47
HYHHF

Hygeia Healthcare

/

+

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Peabody Energy call volume above normal and directionally bullish » 10:45
08/09/22
08/09
10:45
08/09/22
10:45
BTU

Peabody Energy

$20.61 /

+1.425 (+7.43%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

07/07/22 B. Riley
Peabody Energy price target lowered to $33 from $34 at B. Riley
06/07/22 Jefferies
Peabody Energy upgraded to Buy from Hold at Jefferies
05/02/22 B. Riley
Peabody Energy price target raised to $34 from $32 at B. Riley
05/02/22 Benchmark
Peabody Energy price target raised to $29 from $19 at Benchmark
BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

BTU Peabody Energy
$20.61 /

+1.425 (+7.43%)

Hot Stocks
GoodRx rallies after saying grocer issue recently addressed » 10:44
08/09/22
08/09
10:44
08/09/22
10:44
GDRX

GoodRx

$8.13 /

+0.35 (+4.50%)

GoodRx said in last…

GoodRx said in last night's earnings letter, "We are pleased to share that the grocer issue we discussed on our first quarter earnings call was very recently addressed. As communication is rolled out to the grocery chain's pharmacists, we expect GoodRx discounts to be consistently welcomed at the point of sale. We are delighted that our consumers can enjoy the prescription access and affordability benefits of GoodRx at the grocery chain, who we value as a partner. Despite this very recent positive development, we do not anticipate a meaningful volume or revenue lift in the third quarter based on the rollout timeline of relevant communications to the grocery chain's pharmacies, new user adoption and returning user levels. We expect third quarter revenue to be approximately $185 million. This assumes the grocer issue has an estimated impact of $35 million to $40 million on third quarter prescription transactions revenue. We're expecting a greater impact quarter-over-quarter because the effect on the second quarter gradually increased as the quarter developed, whereas we started the third quarter facing a significant impact. In addition to the effect of the grocer issue on prescription transactions revenue, we expect our recent consumer engagement efforts, which we will discuss on our second quarter earnings call, to negatively impact prescription transactions revenue by approximately $5 million in the third quarter." Shares of GoodRx are up 6% to $8.20 in morning trading.

ShowHide Related Items >><<
GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

10:40 Today Goldman Sachs
Goldman Sachs raises GoodRx price target to $10 amid grocer issue resolution
07:58 Today RBC Capital
GoodRx price target raised to $11 from $6.50 at RBC Capital
05:50 Today Barclays
GoodRx price target raised to $13 from $12 at Barclays
07/20/22 Barclays
GoodRx price target lowered to $12 from $15 at Barclays
GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

GDRX GoodRx
$8.13 /

+0.35 (+4.50%)

Hot Stocks
WeTrade Group Inc trading halted, volatility trading pause  10:44
08/09/22
08/09
10:44
08/09/22
10:44
WETG

WeTrade

$17.30 /

-0.9 (-4.95%)

 
ShowHide Related Items >><<
WETG WeTrade
$17.30 /

-0.9 (-4.95%)

  • 19
    Jul
Periodicals
Blue Owl Capital's Dyal in talks to buy stake in PAI Partners, Bloomberg says » 10:43
08/09/22
08/09
10:43
08/09/22
10:43
OWL

Blue Owl Capital

$12.52 /

+0.035 (+0.28%)

Blue Owl Capital's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

07/11/22 JPMorgan
Blue Owl Capital initiated with a Neutral at JPMorgan (Thursday)
06/08/22 JMP Securities
Blue Owl Capital initiated with an Outperform at JMP Securities
01/24/22 BofA
Blue Owl Capital initiated with a Buy at BofA
01/24/22 BofA
Blue Owl Capital initiated with a Buy at BofA
OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

  • 02
    Jun
  • 08
    Dec
OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

OWL Blue Owl Capital
$12.52 /

+0.035 (+0.28%)

Recommendations
Goldman Sachs raises GoodRx price target to $10 amid grocer issue resolution » 10:40
08/09/22
08/09
10:40
08/09/22
10:40
GDRX

GoodRx

$8.28 /

+0.5 (+6.43%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

07:58 Today RBC Capital
GoodRx price target raised to $11 from $6.50 at RBC Capital
05:50 Today Barclays
GoodRx price target raised to $13 from $12 at Barclays
07/20/22 Barclays
GoodRx price target lowered to $12 from $15 at Barclays
07/18/22 Guggenheim
GoodRx price target lowered to $13 from $17 at Guggenheim
GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

GDRX GoodRx
$8.28 /

+0.5 (+6.43%)

Periodicals
Avaya taps Kirkland & Ellis to advise on options, WSJ reports » 10:37
08/09/22
08/09
10:37
08/09/22
10:37
AVYA

Avaya

/

+

Avaya has selected…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVYA Avaya
/

+

AVYA Avaya
/

+

07/29/22 Craig-Hallum
Avaya downgraded to Hold from Buy at Craig-Hallum
07/29/22 Craig-Hallum
Avaya downgraded to Hold from Buy at Craig-Hallum
07/26/22 Barclays
Avaya price target lowered to $2 from $5 at Barclays
06/06/22 Citi
Avaya price target lowered to $6 from $9 at Citi
AVYA Avaya
/

+

AVYA Avaya
/

+

AVYA Avaya
/

+

Options
Warner Bros Discovery Inc put volume heavy and directionally bearish » 10:35
08/09/22
08/09
10:35
08/09/22
10:35
WBD

Warner Bros. Discovery

$13.49 /

-0.52 (-3.71%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

08/08/22 Barrington
Warner Bros. Discovery downgraded to Market Perform from Outperform at Barrington
08/05/22 Wells Fargo
Warner Bros. Discovery downgraded to Equal Weight at Wells Fargo
08/05/22 Barclays
Warner Bros. Discovery price target lowered to $17 from $19 at Barclays
08/04/22 Credit Suisse
Warner Bros. Discovery price target lowered to $43 from $52 at Credit Suisse
WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

WBD Warner Bros. Discovery
$13.49 /

-0.52 (-3.71%)

General news
European Fixed Income Summary: » 10:35
08/09/22
08/09
10:35
08/09/22
10:35
$ECON

Economic Data

/

+

European Fixed Income…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Downgrade
Canoo downgraded to Neutral at Roth Capital on increased need for cash » 10:31
08/09/22
08/09
10:31
08/09/22
10:31
GOEV

Canoo

$3.51 /

-0.445 (-11.27%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

10:28 Today Roth Capital
Canoo downgraded to Neutral from Buy at Roth Capital
08:41 Today R.F. Lafferty
Canoo price target lowered to $15 from $17 at R.F. Lafferty
07/14/22 R.F. Lafferty
Canoo price target lowered to $17 from $20 at R.F. Lafferty
07/13/22 H.C. Wainwright
Canoo price target lowered to $10 from $15 at H.C. Wainwright
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

Downgrade
Canoo downgraded to Neutral from Buy at Roth Capital » 10:28
08/09/22
08/09
10:28
08/09/22
10:28
GOEV

Canoo

$3.51 /

-0.445 (-11.27%)

Roth Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

08:41 Today R.F. Lafferty
Canoo price target lowered to $15 from $17 at R.F. Lafferty
07/14/22 R.F. Lafferty
Canoo price target lowered to $17 from $20 at R.F. Lafferty
07/13/22 H.C. Wainwright
Canoo price target lowered to $10 from $15 at H.C. Wainwright
12/16/21 R.F. Lafferty
Canoo price target raised to $21 from $19 at R.F. Lafferty
GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

GOEV Canoo
$3.51 /

-0.445 (-11.27%)

Hot Stocks
Verona Pharma surges after ensifentrine meets endpoint in COPD study » 10:28
08/09/22
08/09
10:28
08/09/22
10:28
VRNA

Verona Pharma

$12.69 /

+5.76 (+83.12%)

Verona Pharma shares are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

06/17/22 Wedbush
Verona Pharma price target lowered to $18 from $25 at Wedbush
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 H.C. Wainwright
Verona Pharma initiated with a Buy at H.C. Wainwright
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

Earnings
Sysco reaffirms FY24 adjusted EPS guidance 30% higher than FY19 » 10:27
08/09/22
08/09
10:27
08/09/22
10:27
SYY

Sysco

$85.16 /

-1.53 (-1.76%)

Previously provided FY24…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

06/29/22 Barclays
Sysco price target raised to $102 from $97 at Barclays
06/09/22 Barclays
Sysco price target lowered to $97 from $102 at Barclays
05/26/22 JPMorgan
Sysco upgraded to Overweight after recent pullback at JPMorgan
05/26/22 JPMorgan
Sysco upgraded to Overweight from Neutral at JPMorgan
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

Earnings
Verona Pharma reports Q2 EPS (4c), consensus (38c) » 10:27
08/09/22
08/09
10:27
08/09/22
10:27
VRNA

Verona Pharma

$12.69 /

+5.76 (+83.12%)

The company's cash…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

06/17/22 Wedbush
Verona Pharma price target lowered to $18 from $25 at Wedbush
09/13/21
Fly Intel: Top five analyst initiations
09/13/21 H.C. Wainwright
Verona Pharma initiated with a Buy at H.C. Wainwright
VRNA Verona Pharma
$12.69 /

+5.76 (+83.12%)

Earnings
Sysco prepared to generate sales growth of at least 10% in 2023 » 10:27
08/09/22
08/09
10:27
08/09/22
10:27
SYY

Sysco

$85.16 /

-1.53 (-1.76%)

Food away from home is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

06/29/22 Barclays
Sysco price target raised to $102 from $97 at Barclays
06/09/22 Barclays
Sysco price target lowered to $97 from $102 at Barclays
05/26/22 JPMorgan
Sysco upgraded to Overweight after recent pullback at JPMorgan
05/26/22 JPMorgan
Sysco upgraded to Overweight from Neutral at JPMorgan
SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

SYY Sysco
$85.16 /

-1.53 (-1.76%)

Hot Stocks
Liberty TripAdvisor Holdings trading resumes  10:27
08/09/22
08/09
10:27
08/09/22
10:27
 
Options
B. Riley Principal 150 Merger Corp call volume above normal and directionally bullish » 10:25
08/09/22
08/09
10:25
08/09/22
10:25
FAZE

FaZe Holdings

$14.69 /

+0.49 (+3.45%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FAZE FaZe Holdings
$14.69 /

+0.49 (+3.45%)

FAZE FaZe Holdings
$14.69 /

+0.49 (+3.45%)

General news
U.S. IBD/TIPP economic optimism index slipped to -0.4 ticks to 38.1 in August » 10:25
08/09/22
08/09
10:25
08/09/22
10:25
$ECON

Economic Data

/

+

U.S. IBD/TIPP economic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Technical Analysis
NASDAQ market internals summary » 10:17
08/09/22
08/09
10:17
08/09/22
10:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 10:16
08/09/22
08/09
10:16
08/09/22
10:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Options
HP Inc. put volume heavy and directionally bearish » 10:15
08/09/22
08/09
10:15
08/09/22
10:15
HPQ

HP Inc.

$32.81 /

-0.64 (-1.91%)

Bearish flow noted in HP…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HPQ HP Inc.
$32.81 /

-0.64 (-1.91%)

HPQ HP Inc.
$32.81 /

-0.64 (-1.91%)

07/14/22 JPMorgan
HP Inc. price target lowered to $36 from $39 at JPMorgan
07/05/22 Evercore ISI
HP downgraded to In Line at Evercore on fears of 'more severe' PC headwinds
07/05/22 Evercore ISI
HP Inc. downgraded to In Line from Outperform at Evercore ISI
06/02/22 Evercore ISI
HP Inc. removed from 'Tactical Outperform' list at Evercore ISI
HPQ HP Inc.
$32.81 /

-0.64 (-1.91%)

HPQ HP Inc.
$32.81 /

-0.64 (-1.91%)

HPQ HP Inc.
$32.81 /

-0.64 (-1.91%)

HPQ HP Inc.
$32.81 /

-0.64 (-1.91%)

Hot Stocks
Virgin Orbit announces pact with South Korean investment group J-Space » 10:13
08/09/22
08/09
10:13
08/09/22
10:13
VORB

Virgin Orbit

$3.77 /

-0.05 (-1.31%)

Virgin Orbit announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VORB Virgin Orbit
$3.77 /

-0.05 (-1.31%)

VORB Virgin Orbit
$3.77 /

-0.05 (-1.31%)

06/28/22 Canaccord
Virgin Orbit's Brazil approval demonstrates solid execution, says Canaccord
05/12/22 Canaccord
Virgin Orbit price target lowered to $12 from $20 at Canaccord
02/28/22 Canaccord
Canaccord starts Virgin Orbit at Buy, sees 'exceptional market opportunity'
02/28/22 Canaccord
Virgin Orbit initiated with a Buy at Canaccord
VORB Virgin Orbit
$3.77 /

-0.05 (-1.31%)

VORB Virgin Orbit
$3.77 /

-0.05 (-1.31%)

VORB Virgin Orbit
$3.77 /

-0.05 (-1.31%)

Hot Stocks
Liberty TripAdvisor Holdings trading halted, volatility trading pause  10:12
08/09/22
08/09
10:12
08/09/22
10:12
 
Hot Stocks
Clearside Biomedical jumps following financing pact with HealthCare Royalty » 10:11
08/09/22
08/09
10:11
08/09/22
10:11
CLSD

Clearside Biomedical

$1.79 /

+0.155 (+9.48%)

Shares of Clearside…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLSD Clearside Biomedical
$1.79 /

+0.155 (+9.48%)

CLSD Clearside Biomedical
$1.79 /

+0.155 (+9.48%)

12/22/21 Roth Capital
Roth says Clearside data 'certainly supportive' of dose-escalation in Wet AMD
12/21/21 JMP Securities
JMP remains bullish on Clearside as Cohort 2 in OASIS adds to CLS-AX potential
12/15/21 Wedbush
Clearside Biomedical assumed with an Outperform at Wedbush
10/25/21 Roth Capital
Clearside Biomedical price target raised to $17 from $15 at Roth Capital
CLSD Clearside Biomedical
$1.79 /

+0.155 (+9.48%)

Hot Stocks
Avaya says board committee investigating whistleblower letter » 10:10
08/09/22
08/09
10:10
08/09/22
10:10
AVYA

Avaya

/

+

Along with Avaya having…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AVYA Avaya
/

+

AVYA Avaya
/

+

07/29/22 Craig-Hallum
Avaya downgraded to Hold from Buy at Craig-Hallum
07/29/22 Craig-Hallum
Avaya downgraded to Hold from Buy at Craig-Hallum
07/26/22 Barclays
Avaya price target lowered to $2 from $5 at Barclays
06/06/22 Citi
Avaya price target lowered to $6 from $9 at Citi
AVYA Avaya
/

+

AVYA Avaya
/

+

AVYA Avaya
/

+

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.